Latest News Archive
Please select Category, Year, and then Month to display items
07 January 2018
Photo Charl Devenish
Dr Anneke van der Spoel van Dijk is invested in contributing
to the global effort of stopping TB by 2035.
The work of Dr Anneke van der Spoel van Dijk investigates the spread of TB in the Free State population using techniques such as next generation sequencing, spoligotyping and MIRU-VNTR typing. Dr Van der Spoel van Dijk, a senior medical scientist in the Department of Medical Microbiology at the University of the Free State (UFS) also looks at drug resistance in her research. This work informs decisions about how best to treat patients with multidrug-resistant TB (MDR-TB).
She employs rapid molecular techniques to track one of Africa’s most serious diseases, tuberculosis (TB).
Drug resistance
Scientists assist the National Health Laboratory Service and Department of Health in trying to refine the diagnostic tools to identify these cases earlier. Dr Van der Spoel van Dijk explains: “Until recently, it took up to two years to fine-tune treatment decisions for patients with MDR-TB. Patients get a cocktail of anti-TB drugs, but it takes time to find the right combination. Re-infection and relapse (patients stopping treatment for several reasons) add to the diagnostic and treatment management challenges.
Enormous impact
“Now doctors can reduce the time needed for diagnostic certainty to about seven days, while new drugs allow reduction of treatment from more than 18 to nine months. This can have an enormous impact on the life of many patients.”
Dr Van der Spoel van Dijk’s work forms part of research in the faculty looking at resistance development in TB strains. She is currently also doing her doctoral thesis on the differences and incidence of MDR-TB among adolescents versus adults. Dr Van der Spoel van Dijk says: “It is a complicated picture, but we hope to unravel it to support better diagnostic tools and patient care.”
As part of the National Health Laboratory Service, her department is playing an important role in TB diagnostics and the training of scientists and future pathologists. “Our work is contributing to the global vision to stop TB by 2035,” Dr Van der Spoel van Dijk says.
Full accreditation for MBA programme
2004-12-01
|
The University of the Free State (UFS) this week received full accreditation for its MBA-programme from the Council on Higher Education (CHE). The accreditation was granted after the programme was conditionally accredited earlier this year.
“The full accreditation serves as proof that the key elements of a good teaching programme are in place. After the programme received conditional accreditation, a few areas were addressed and a progress report was submitted to the CHE. This was followed by a site visit by a delegation from the CHE. We are happy about the successful outcome of the accreditation process,” said Prof Helena van Zyl, Director of the UFS’s School of Management.
“In the initial evaluation done by the CHE it was already mentioned that the UFS’s MBA-programme clearly and significantly contributes to students’ knowledge and skills, is relevant for the workplace and appropriately resourced. Now we can build on the further extension of the quality of the programme,” said Prof van Zyl.
“We welcome the CHE’s accreditation process. It confirms and protects the integrity of the group of high quality MBA-programmes in South Africa,” said Prof Frederick Fourie, Rector and Vice-Chancellor of the UFS.
The UFS’s online MBA-programme will only be evaluated next year because the CHE is still in the process of developing criteria for the on-line programmes of tertiary institutions.
|
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
7 December 2004 |